stock.name

Altimmune Inc

ALT

Market Cap$488.47M
Close$

Compare Altimmune

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Altimmune IncAltimmune Inc00%---
marketMarket Avg591.3%30%-1
HealthcareHealthcare Avg64.41.34%15%-0.9
$12.00

Target Price by Analysts

60.6% upsideAltimmune Target Price DetailsTarget Price
$2.52

Current Fair Value

66.3% downside

Overvalued by 66.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$488.47 Million
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Beta1.68
Outstanding Shares70,895,286
Avg 30 Day Volume3,774,375

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Altimmune Inc

CEO: Vipin Garg